BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang K, Ji F, Xie Z, Wu D, Xu X, Gao H, Ouyang X, Xiao L, Zhou M, Zhu D, Li L. Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis. Sci Rep 2019;9:16462. [PMID: 31712684 DOI: 10.1038/s41598-019-53029-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Shetty R, Murugeswari P, Chakrabarty K, Jayadev C, Matalia H, Ghosh A, Das D. Stem cell therapy in coronavirus disease 2019: current evidence and future potential. Cytotherapy 2021;23:471-82. [PMID: 33257213 DOI: 10.1016/j.jcyt.2020.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang L, Zhu S, Liu Y, Zheng L, Xu W, Luo Q, Zhang Y, Deng H, Li X, Xie C, Peng L. Prognostic value of decline in model for end-stage liver disease score and hepatic encephalopathy in hepatitis B-related acute-on-chronic liver failure patients treated with plasma exchange. Scandinavian Journal of Gastroenterology. [DOI: 10.1080/00365521.2022.2063032] [Reference Citation Analysis]
3 Ling S, Jiang G, Que Q, Xu S, Chen J, Xu X. Liver transplantation in patients with liver failure: twenty years of experience from China. Liver Int 2022. [PMID: 35532977 DOI: 10.1111/liv.15288] [Reference Citation Analysis]
4 Philips CA, Ahamed R, Abduljaleel JK, Rajesh S, Augustine P. Critical Updates on Chronic Hepatitis B Virus Infection in 2021. Cureus 2021;13:e19152. [PMID: 34733599 DOI: 10.7759/cureus.19152] [Reference Citation Analysis]
5 Sleem A, Saleh F. Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy. Curr Res Transl Med 2020;68:105-10. [PMID: 32616467 DOI: 10.1016/j.retram.2020.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Ye Y, Li X, Zhu L, Yang C, Tan YW. Establishment of a risk assessment score for deep vein thrombosis after artificial liver support system treatment. World J Clin Cases 2021; 9(31): 9406-9416 [PMID: 34877276 DOI: 10.12998/wjcc.v9.i31.9406] [Reference Citation Analysis]
7 Yao W, Shi L, Zhang Y, Dong H, Zhang Y. Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives. Stem Cell Res Ther 2022;13:124. [PMID: 35321737 DOI: 10.1186/s13287-022-02810-6] [Reference Citation Analysis]
8 Liu H, Zhang Q, Liu L, Cao Y, Ye Q, Liu F, Liang J, Wen J, Li Y, Han T. Effect of artificial liver support system on short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Artif Organs 2020;44:E434-47. [PMID: 32320491 DOI: 10.1111/aor.13710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Yu M, Li X, Lu Y, Jie Y, Li X, Shi X, Zhong S, Wu Y, Xu W, Liu Z, Chong Y. Development and Validation of a Novel Risk Prediction Model Using Recursive Feature Elimination Algorithm for Acute-on-Chronic Liver Failure in Chronic Hepatitis B Patients With Severe Acute Exacerbation. Front Med (Lausanne) 2021;8:748915. [PMID: 34790679 DOI: 10.3389/fmed.2021.748915] [Reference Citation Analysis]
10 Du L, Ma Y, Zhou S, Chen F, Xu Y, Wang M, Lei X, Feng P, Tang H, Bai L. A prognostic score for patients with acute-on-chronic liver failure treated with plasma exchange-centered artificial liver support system. Sci Rep 2021;11:1469. [PMID: 33446902 DOI: 10.1038/s41598-021-81019-8] [Reference Citation Analysis]